A detailed history of Sg Americas Securities, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,995 shares of CELC stock, worth $101,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,995
Holding current value
$101,536
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$13.98 - $19.15 $111,770 - $153,104
7,995 New
7,995 $119,000
Q1 2024

May 06, 2024

SELL
$13.74 - $21.6 $43,335 - $68,126
-3,154 Reduced 33.1%
6,375 $138,000
Q4 2023

Jan 12, 2024

BUY
$8.7 - $15.02 $82,902 - $143,125
9,529 New
9,529 $139,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $190M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.